Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer

PURPOSE: Cancer patients with bone metastases (BMets) are predisposed to skeletal complications. Bone-targeted therapies such as denosumab or intravenous bisphosphonates (IVBs) reduce the risk of these complications. This study characterized patterns of IVB use in these patients in the USA. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagiwara, May, Delea, Thomas E., Cong, Ze, Chung, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843817/
https://www.ncbi.nlm.nih.gov/pubmed/24000042
http://dx.doi.org/10.1007/s00520-013-1951-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843817/
https://www.ncbi.nlm.nih.gov/pubmed/24000042
http://dx.doi.org/10.1007/s00520-013-1951-z

Ejemplares similares